PAIGE JONITES: Open Payments
NPI 1205534674 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,519 in 99 payments from 17 companies in 2025. Trend: 2023 $677 · 2024 $800 · 2025 $2,519
Food & beverage: $2,352Education: $167
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $409 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $378 |
| ABBVIE INC. | 18 | $294 |
| Novartis Pharmaceuticals Corporation | 10 | $242 |
| Incyte Corporation | 7 | $186 |
| Janssen Biotech, Inc. | 5 | $165 |
| LEO Pharma Inc. | 5 | $128 |
| Regeneron Healthcare Solutions, Inc. | 4 | $126 |
| Amgen Inc. | 4 | $113 |
| UCB, Inc. | 4 | $103 |
Products named: DUPIXENT, ILUMYA, OPZELURA, TREMFYA, SKYRIZI, COSENTYX, RINVOQ, ADBRY.
Industry payments across IL — which companies pay providers there.
